According to multiple media reports, the number of COVID-19 cases in Australia has surged recently, and is experiencing the eighth wave of COVID-19, which is feared to reach "a peak for the third consecutive year" by Christmas.

Recently, the new coronavirus (2019-nCoV) antigen detection kit (Colloidal gold method) developed by Xiamen Wiz Biotech Co., Ltd. has been approved by the National Medical Products Administration.

According to the latest HSC Common List published on October 17, 2022, the SARS-CoV-2 Antigen Rapid Test produced by Wizbiotech has been listed in HSC Common List Class A.

As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.

COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,